Early discharge of patients with venous Thromboembolism: Implications regarding therapy

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 2, 2010, Pages 141-145

  Stein, Paul D ^a   Hull, Russell D ^b   Matta, Fadi ^a   Yaekoub, Abdo Y ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c ST JOSEPH MERCY OAKLAND HOSPITAL   (United States)

Author keywords

Deep venous thrombosis; Early discharge; Heparin; Hospitalization; Pulmonary embolism; Venous thromboembolism; Warfarin

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; COST SAVINGS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; PATIENT DISCHARGE; PATIENT SELECTION; POLYSACCHARIDES; PULMONARY EMBOLISM; UNITED STATES; VENOUS THROMBOSIS; WARFARIN;

EID: 77949879999     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609342093     Document Type: Article

References (27)

1. Stein PD In: Pulmonary Embolism. 2 nd ed. Oxford: Blackwell Furtura ; 2007: 70-74.
2. White RH, Zhou H., Romano PS Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. Arch Intern Med. 1998 ; 158 (9). 1005-1010.
3. Aujesky D., Stone RA, Kim S., Crick EJ, Fine MJ Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective. Arch Intern Med. 2008 ; 168 (7). 706-712.
4. Kozak LJ, DeFrances CJ, Hall MJ National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2006 ;(162). 1-209.
5. Kearon C., Kahn SR, Agnelli G., Goldhaber S., Raskob GE, Comerota AJ, and the American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8 th Edition). Chest. 2008 ; 133 (6 suppl). 454S - 545S.
6. Hull RD, Raskob GE, Rosenbloom D., et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med. 1990 ; 322 (18). 1260-1264.
7. Gallus A., Jackaman J., Tillett J., Mills W., Wycherley A. Safety and efficacy of warfarin started early after sub-massive venous thrombosis or pulmonary embolism. Lancet. 1986 ; 2 (8519). 1293-1296.
8. Rosiello RA, Chan CK, Tencza F., Matthay RA Timing of oral anticoagulation therapy in the treatment of angiographically proven acute pulmonary embolism. Arch Intern Med. 1987 ; 147 (8). 1469-1473.
9. Levine M., Gent M., Hirsh J., et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. N Engl J Med. 1996 ; 334 (11). 677-681.
10. Koopman MM, Prandoni P., Piovella F., et al. for the Tasman Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996 ; 334 (11). 682-687.
11. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med. 1997 ; 337 (10). 657-662.
12. Janjua M., Badshah A., Matta F., Danescu LG, Yaekoub AY, Stein PD Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review. Thromb Haemost. 2008 ; 100 (5). 756-761.
13. US Department of Health and Human Services, Public Health Service, National Center for Health Statistics, National Hospital Discharge Survey 1979-1999. Multi-year Public-Use Data File Documentation. http://www.cdc.gov/ nchs/about/major/hdasd/nhds.htm. Accessed July 1, 2008.
14. Kucher N., Quiroz R., McKean S., Sasahara AA, Goldhaber SZ Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism. Vasc Med. 2005 ; 10 (4). 251-256.
15. Castro DJ, DÍaz G., MartÍ D., et al. Monotherapy with enoxaparin for the prevention of recurrent venous thromboembolism. Blood Coagul Fibrinolysis. 2007 ; 18 (2). 173-177.
16. Wessler S., Morris LE Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis. Circulation. 1955 ; 12 (4). 553-556.
17. Carey LC, Williams RD Comparative effects of dicoumarol, tromexan, and heparin on thrombus propagation. Ann Surg. 1960 ; 152: 919-922.
18. Wessler S., Gitel SN Warfarin. From bedside to bench. N Engl J Med. 1984 ; 311 (10). 645-652.
19. Zivelin A., Rao LV, Rapaport SI Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors. J Clin Invest. 1993 ; 92 (5). 2131-2140.
20. Harrison L., Johnston M., Massicotte MP, Crowther M., Moffat K., Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med. 1997 ; 126 (2). 133-136.
21. Meux EF, Stith SA, Zach A. Report of Results from the OSHPD Reabstracting Project: An Evaluation of the Reliability of Selected Patient Discharge Data, July through December 1988. Sacramento, CA: Office of Statewide Health Planning and Development ; 1990.
22. White RH, Zhou H., Romano PS Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 1998 ; 128 (9). 737-740.
23. Kniffin WD Jr, Baron JA, Barrett J., Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 1994 ; 154 (8). 861-866.
24. Stein PD, Kayali F., Olson RE, Milford CE Pulmonary thromboembolism in Asian/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med. 2004 ; 116 (7). 435-442.
25. Proctor MC, Greenfield LJ Pulmonary embolism: diagnosis, incidence, and implications. Cardiovasc Surg. 1997 ; 5 (1). 77-81.
26. Stein PD, Henry JW Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995 ; 108 (4). 978-981.
27. Stein PD, Patel KC, Kalra NK, et al. Estimated incidence of acute pulmonary embolism in a community/teaching general hospital. Chest. 2002 ; 121 (3). 802-805.